Welcome to our dedicated page for Utah Med Prods news (Ticker: UTMD), a resource for investors and traders seeking the latest updates and insights on Utah Med Prods stock.
Utah Medical Products Inc. (UTMD) delivers innovative medical devices for critical healthcare needs, specializing in women's health and neonatal care. This news hub provides investors and healthcare professionals with timely updates on corporate developments, regulatory milestones, and clinical advancements.
Access consolidated information on quarterly earnings, product approvals, and strategic partnerships that shape UTMD's leadership in medical technology. Our repository includes press releases detailing innovations in electrosurgical tools, neonatal monitoring systems, and disposable medical devices used globally.
Key updates cover FDA clearances, manufacturing expansions, and clinical study results impacting healthcare delivery. Bookmark this page for streamlined tracking of UTMD's progress in developing devices that meet rigorous hospital standards across 100+ countries.
Utah Medical Products, Inc. (NASDAQ: UTMD) announced a 1.7% increase in their quarterly cash dividend to thirty cents ($.30) per share of common stock. The dividend will be payable on July 5, 2024, to stockholders of record as of June 14, 2024. The company specializes in health care products for women and babies, with a global presence in over a hundred countries.
FAQ
What is the current stock price of Utah Med Prods (UTMD)?
What is the market cap of Utah Med Prods (UTMD)?
